DigitalOwl vs Wisedocs: how they compare in 2026

The models are the entire product and there is nothing underneath them. DigitalOwl does one thing, converting unstructured medical records into structured data, and every part of that is model work: extraction from conventional and electronic health records, chronology construction, impairment and body part classification, identification of soft medical terms, condition status change detection, and a chat interface over the record set. The vendor states the AI is proprietary, built by in house experts and trained specifically for these use cases rather than adapted from a general tool. Connect exposes the model output as an API for other systems to consume, which is the clearest possible statement that the extraction is the asset. Remove the models and there is no product, only a file upload. Fifth consecutive A on this axis in this category. Entered under brief ruling 2 as an acquired product still sold under its own name, with Datavant named as owner.

The machine learning is the mechanism the buyer pays for. The product reads unstructured medical and claims files and produces sorted, indexed, deduplicated chronologies and cited summaries with red flags; the human validation layer checks the model's output rather than producing its own, and the vendor's founding product in 2023 was the AI medical summaries platform. Remove the models and there is a document store and a review queue. Home page, medical summaries page and 2025 WiseChat release read 6 September 2026.

THE FIRST PUBLISHED ACCURACY FIGURE IN THIS CATEGORY, and it is short of the evidence that would make it checkable. The vendor states the platform is third party tested at over 98 percent accuracy. In 45 records almost nothing on this index publishes a number here at all, and this vendor publishes one and attributes it to independent testing, which is materially more than its four category peers. What is missing is everything that would let a reader test it: no evaluator is named, no methodology, no sample size, no test corpus, no date, and critically no definition of what accuracy means for this task. Extraction accuracy could mean correctly transcribed values, correctly classified pages, correctly ordered events or correctly identified providers, and those are very different measures producing very different numbers. Held at B on that basis rather than A. The number is credited as a real disclosure and the note records that a figure without a definition or an evaluator cannot be verified or compared. Checked the self serve page, the SSP product page, the home page, the View and Connect product pages and the blog material on 29 Aug 2026.

Grounding is real and documented with links to source, and a benchmark exists, short of a published accuracy figure for the product itself on the surfaces read. Every summary is stated to be hyperlinked to its original document with citations at the fact level, and each summary passes human-in-the-loop validation before release; the home page states the company released the Medical Long Context Reasoning benchmark to measure how models reason across long fragmented medical records and an independently run edition with Artificial Analysis, which is a testing regime, but the benchmark page was not opened and whether it reports Wisedocs' own product accuracy is not established. The FAQ answers the accuracy question qualitatively. The benchmark page is the rebuttal route to A. Medical summaries page, home page and FAQ read 6 September 2026.

A clear positioning statement exists and no operational boundary does. The vendor states plainly in published material that the platform is a tool to support legal professionals rather than replace them and that it cannot substitute for legal professionals' judgment, decision making or expertise. That is an unusually direct disclaimer of substitution and is more than most of this index offers. It is a statement about role rather than a description of the oversight model. Nothing published states whether any extraction or classification is applied without human review, whether a low confidence result is surfaced differently, what happens when the chat interface answers a question the records do not support, or what review the Self-Serve pipeline receives before output is delivered inside 24 hours. Checked the self serve page, the SSP product page, the View and Connect pages and the blog material on 29 Aug 2026.

What runs alone, what a person must validate, where the review sits and what constrains it are all published. Modes: sorting, indexing, deduplication and co-mingled claimant detection run automatically; every medical summary passes through human-in-the-loop validation by trained expert reviewers before release. Review surface: users are notified when verified documents are ready for final review, every fact is cited to its source page, and activity logs track actions. Constraints: review templates turn the customer's case strategy into the focus of the review, and the enterprise page states explainable models and audit trails. Route back: the customer's own final review sits after the expert validation. Nothing states a confidence threshold below which a summary is held back, which is the one limb short. Medical summaries page, enterprise page and claims legal page read 6 September 2026.

Independent recognition and a corporate outcome are both dated and checkable, and no customer is named. Independent and verifiable: the Self-Serve legal platform was named an Innovative Product Winner in the 2026 BIG Innovation Awards, a named program with a dated announcement, and the company was acquired by Datavant in 2025, which is an arm's length transaction by a major health data company and is the strongest single validation event on this record. Published operational figures are specific: up to 72 percent of medical record review time saved, review time reduced by up to 50 percent, page count reduced by 90 percent, and a thousand page record reviewed in minutes. Held at B rather than A because no law firm, carrier or customer is named anywhere in located material, no case study with methodology exists, and every efficiency figure carries an up to qualifier with no baseline, sample or period. Same treatment as Exterro, which reached B on independent analyst placement with no named customer.

Figures without a named customer on the surfaces read. The home page states sixty to eighty percent faster first touch and up to three times lower manual review cost, the medical summaries page up to seventy percent faster record reviews, and a careers listing eighty-five percent time and fifty-five percent cost reduction, all unattributed; the vendor states a customer base that more than doubled at its 2024 raise. A customer stories section exists in the navigation and was not opened, and is the rebuttal route. Home page, product page and release read 6 September 2026.

A strong instrument set, and a structural conflict question this vendor raises more sharply than anything else on the index. Published: SOC 2 Type II, HIPAA and GDPR compliance, a business associate agreement offered to customers and covered entities, secure storage of uploaded records, and customer controlled manual deletion at any time. That is the second BAA on the index and a genuine set of protections for the claimant health information at stake. THE UNADDRESSED QUESTION: this vendor sells to both sides. Its legal offering serves plaintiff personal injury, medical malpractice and mass tort firms, and its insurance offering explicitly includes streamlining review of inbound settlement demand packages and bodily injury claims for carriers. Those are the same disputes viewed from opposite ends, and nothing published describes what separates a plaintiff firm's uploaded records and case insights from the carrier side of the business. No treatment of attorney client privilege or work product was located either. Held at B on the strength of the instruments, with the conflict question named rather than buried.

Substantive published commitments on segregation and deployment, with an adverse training position stated and privilege not named. Segregation at the level an in-house or firm buyer requires: role-based access, SAML single sign-on, SCIM provisioning, activity logs and data access safeguards, with private cloud, on-premise and hybrid deployment available. Training: the enterprise page states anonymized training methods and the vendor states models trained on more than a hundred million documents, which is a published position that customer content trains after anonymization, with no agreement located either way. Third-party providers: regional model hosting is offered without naming the providers. Retention and deletion: not located, and no customer agreement was located. Nothing addresses privilege or work product for a product whose legal buyers use it to build causation and liability arguments. Enterprise page and product pages read 6 September 2026.

The claim is made and no framework sits behind it. The vendor publishes an explicit statement that the platform is a tool to support legal professionals and not replace them, and that it cannot substitute for their judgment, decision making or expertise, made in the context of addressing attorney resistance to adoption. That is a direct and relevant position and it is the reason this grades above the D that most of this category receives. What is absent: no statement that output is not legal advice, no positioning on the supervising attorney's duty over machine extracted medical facts that will support a demand, no guidance on verification before reliance, and no engagement with any bar guidance. A sentence in a blog post addressing adoption anxiety is a claim rather than a professional responsibility framework. Checked the blog material, the self serve page, the product pages and the site navigation on 29 Aug 2026.

No advice line or supervision statement was located. The defence-lawyer, claims-legal and malpractice pages sell the product to attorneys and paralegals as producing defensible, audit-ready documentation, and the human-in-the-loop design is described in terms of clinical accuracy; no surface read states that summaries are not legal or medical advice, who should rely on them, or how the product supports a supervising lawyer's duties, and no customer agreement was located to carry such a statement. Role pages and product pages read 6 September 2026.

The vendor tells buyers to demand exactly the disclosure it does not make, which is the third instance of this pattern in the pull after LinkSquares and FinregE. Its own published buyer guidance advises firms evaluating medical chronology software to ask whether the platform has undergone independent bias and accuracy testing, and states that reputable providers will be transparent about their validation processes and able to demonstrate their AI produces reliable, unbiased results across different case types and medical conditions. DigitalOwl publishes an accuracy figure and nothing on bias. No bias or fairness testing, no validation methodology, no AI policy, no model card, no evaluation output, no accuracy monitoring, no named governance body and no ISO 42001 were located. The untested risk is concrete for a product extracting clinical facts: documentation quality and diagnostic language vary systematically across providers and patient populations, and an extraction model's performance differences across those populations would shape which injuries appear in a demand. Fifth consecutive D on this axis in this category.

A published governance statement with real mechanisms and a testing program, short of a named owner or bias findings. The enterprise page's AI Governance section states human-in-the-loop validation, audit trails, explainable models and anonymized training methods as the basis for ethical, accurate and accountable AI, and the company has published the Medical Long Context Reasoning benchmark with an independently run edition through Artificial Analysis, which is a public testing regime for the class of models it uses. No ISO 42001 or equivalent certification, no accountable owner and no statement about uneven output across record types is published on the surfaces read. Enterprise page and home page read 6 September 2026.

The best data control disclosure in this category, and the training question remains unanswered. Published and specific: records uploaded to the Self-Serve portal are securely stored and the customer can manually delete their data at any time, which is a user exercisable control rather than a policy assurance and is the only such control located in this category. Alongside it a business associate agreement, SOC 2 Type II, HIPAA and GDPR compliance, and a published trust page. GDPR compliance carries data subject rights machinery that matters here because the individual whose records these are is a third party to the customer relationship. Held at B rather than A because nothing states whether uploaded medical records, generated chronologies or extracted structured data are used to train or improve the proprietary models, no retention period is published for data the customer does not delete, and nothing describes what happens to derived structured output when the source records are deleted. A deletion control is a strong answer to how long, and not an answer to what for.

Some of the ground is covered and the rest was not located. Access control: role-based access, SAML single sign-on, SCIM provisioning, full activity logs and data access safeguards on the enterprise page, with SOC 2 Type II and HIPAA compliance stated. Not located: a retention period, a deletion commitment, a sub-processor list or an incident-notification practice; no customer agreement, DPA or trust center was located on the surfaces read, and the privacy policy was not opened and is the rebuttal route. Enterprise page and product pages read 6 September 2026.

No published position located beyond the BAA, which allocates HIPAA obligations between the parties rather than product liability. Nothing was found on liability for AI output, warranty, service levels or remedy. The exposure is asymmetric in a way particular to this product: a missed diagnosis, an omitted provider or a misdated treatment in an extracted chronology understates an injury, and on the plaintiff side that flows into a demand that settles low while on the carrier side it supports a denial, so the same extraction error harms a claimant in both directions. The published 98 percent accuracy figure implies a residual error rate by its own arithmetic and no published position addresses who bears it. Checked the self serve page, the product pages, the trust page references and the site navigation on 29 Aug 2026.

No liability position was located on the surfaces that could be read. Product, role, enterprise and use-case pages describe defensibility of outputs without any indemnity, cap, warranty or insurance position, and no terms of service or customer agreement surfaced in search or in the material read; the site footer was not inventoried, so whether an agreement exists is not established. This records what is locatable on the date and not a finding that no position exists; any published agreement is the rebuttal route. Surfaces read 6 September 2026.

A real integration product exists and it is aimed at the other half of the customer base. Connect is a medical data API allowing clients to retrieve and integrate structured output into rules engines, workbenches and custom workflows, and it is sold as a named product rather than mentioned as a capability, which is genuine integration substance. The language and the named destinations are insurance systems: rules engines and workbenches are carrier claims and underwriting infrastructure, not law firm systems. No legal case management system is named anywhere in located material, no document management connector, and no integration with the platforms a personal injury firm runs on. A plaintiff firm gets a self serve upload portal and an API it would need to build against itself. Compare Tavrn at B, naming Filevine, Litify, Clio and Smokeball alongside API access. Checked the Connect product page, the self serve page, the SSP product page and the site navigation on 29 Aug 2026.

Integrations are referred to without documentation an implementer could use on the surfaces read. The enterprise page describes disconnected systems as the problem the platform solves and offers SAML and SCIM identity integration, and the platform accepts drag-and-drop upload of PDFs, faxes and images; no claims system, case management platform or document management integration is named with what moves and in which direction, and no integrations page was opened. Enterprise page and product pages read 6 September 2026.

Nothing located. No hosting provider is named, no region or data residency commitment is published, and no single tenant or dedicated instance option is described. Stated GDPR compliance implies the vendor handles European personal data and says nothing about where it is processed or stored, and a company holding United States claimant medical records under HIPAA alongside European obligations is exactly the case where residency would be stated if it were designed for. Compare Supio at B, which names data centers in three countries. Checked the self serve page, the SSP product page, the trust page references, the product pages and the site navigation on 29 Aug 2026.

Deployment options are published with tenancy, residency and model-processing location. The enterprise page states that Wisedocs is offered as multi-tenant SaaS, private cloud, on-premise or hybrid deployment, that regional model hosting is supported to meet data residency requirements, and that high-availability architecture underlies the enterprise tier; that answers who shares infrastructure, where data sits and where the models run. Specific regions are not enumerated. Enterprise page read 6 September 2026.

Three regimes, a trust page, and the second BAA on the index, held below A on currency alone. Published: SOC 2 Type II, HIPAA and GDPR compliance, a business associate agreement offered to customers and covered entities, and a dedicated trust page published as Trust at DigitalOwl and linked from product pages. Offering a BAA is the instrument HIPAA actually requires rather than a claim about compliance, and it puts this record alongside Tavrn as one of only two on the index to do so. Held at B rather than A on the same absences that separate the tiers: no auditing firm is named, and no examination period, scope or certificate date is published for the SOC 2, so currency cannot be established at all. That is the specific gap EvenUp closes with a dated April 2026 recertification to reach A, and it is the only material difference between the two records on this axis. Correction candidate: the trust page itself was not read in this pass and is the surface most likely to carry dates and scope.

Certification is real and dated, short of a report reachable without asking. The vendor announced SOC 2 Type II compliance on 13 August 2024 with zero findings across security, availability, processing integrity, confidentiality and privacy, and states HIPAA compliance across its role pages. No auditor, coverage period, report route or trust center is stated on the surfaces read. SOC 2 announcement and role pages read 6 September 2026.

Nothing located. The AI is described as proprietary and built by in house experts, which is an ownership statement rather than a supply chain disclosure, and no foundation model provider, model family or version is named. No subprocessor list was found. The acquisition adds an unaddressed dimension rather than resolving one: Datavant is a health data platform company and nothing published describes what data or processing relationship now exists between the two, which for a business associate handling protected health information is a question a covered entity is entitled to have answered. Checked the product pages, the self serve page, the blog material including the acquisition post and the site navigation on 29 Aug 2026.

The supply chain is partly disclosed. The vendor states its models are domain-trained on more than a hundred million documents, that regional model hosting is available so inference can be placed by residency requirement, and that its MLCR benchmark evaluates frontier closed- and open-weight models, which implies third-party models in the stack; no provider or model is named and no change-notification commitment is stated. Enterprise page, home page and directory description read 6 September 2026.

No pricing published by the vendor at any level. No price, no range, no unit of charge, and no indication of whether the Self-Serve portal prices per case, per page, per record set or by subscription, which matters because a self serve product is precisely the configuration where a firm expects to see a price before engaging. An independent review platform reports a starting figure of $7,500 per month, which is third party reconstruction rather than disclosure and is recorded as context rather than credited, and if approximately right it places the product well outside small firm reach. The contingency fee point recorded across this category applies: case costs are advanced against a claimant's recovery, so undisclosed cost is undisclosed cost to an injured person. Checked the self serve page, the SSP product page, the pricing navigation and independent review material on 29 Aug 2026.

No pricing information was located at any level. The site offers a demo and a call to discuss claims workflows, and no unit of charge, tier, figure or pricing page appears in the material read; the footer was not inventoried, so the absence of a pricing page is not established by inventory and this row is rebuttable on one if it exists. Home page, product and enterprise pages read 6 September 2026.

The broadest coverage in this category by a wide margin, spanning both sides of the market. Legal coverage names personal injury, medical malpractice and mass tort. Insurance coverage names underwriting, claims review, post issue audits, long term care application review for material misrepresentation, workers compensation, property and casualty claims, bodily injury, and review of inbound settlement demand packages. Record coverage extends to both conventional and electronic health records, which is a meaningful technical distinction since EHR exports and scanned paper files present different extraction problems. Held at B rather than A because breadth is asserted rather than characterized: no statement of which record formats, provider systems or document types the extraction handles reliably, no jurisdictional scope, and no indication of whether the 98 percent accuracy figure holds evenly across record types or was measured on a favorable subset. Breadth without a characterized boundary is the same gap as everywhere else on this axis.

Segment and coverage are described with substance and the boundaries are partly stated. The vendor names workers' compensation, auto and casualty, disability, liability, healthcare, legal defense, government and IME and QME claims as supported review types, role pages for defense lawyers, claims legal teams, claims adjusters and evaluators, a malpractice use case with files exceeding a hundred thousand pages, and North American operation. The legal pages are written for the defense side, which is a stated orientation; no jurisdiction or record type is named as unsupported. Home page, role pages and use-case page read 6 September 2026.